Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Table 2
Baseline characteristics and clinical variables for all 36 patients.
Characteristic
(%)
Age (years)
āMedian (range)
60 (46ā79)
Sex
āFemale
10 (28%)
āMale
26 (72%)
Raceā
āCaucasian
22 (61%)
āAfrican-American
12 (33%)
āOther
2 (5%)
Performance status (ECOG)
ā0
8 (22%)
ā1
26 (72%)
ā2
2 (6%)
Prior chemo-radiotherapy
āNo
1 (3%)
āYes
35 (97%)
Sites of metastasis
āLungā
21 (58%)
āLiver
2 (6%)
āOther
6 (17%)
Treatment cycles administered
āMedian (range)
4 (0ā24)
Percentages may not sum up to 100 due to rounding. Multiple sites of metastasis may have occurred in the same patient.